Truist raised the firm’s price target on Privia Health (PRVA) to $27 from $24 and keeps a Buy rating on the shares after its Q3 earnings beat. The company has had record new provider signings ...
The market expects Privia Health (PRVA) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback